# US 2026/0062437 A1 · Antiviral compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0062437 A1
- Document ID: US20260062437A1
- Status: Published application
- Kind: A1
- Application number: 19/106,120
- Filed: 2023-08-25
- Published: 2026-03-05
- Earliest claimed: 2022-08-26
- Assignees: Regents of the University of Minnesota
- Applicants: Regents of the University of Minnesota
- Inventors: Daniel Allen Harki; Samantha Anne Kennelly; Jacob Matthew Sawyer
- Web page: https://patentgrep.com/patent/US20260062437A1

## CPC

- C07F 9/65586: {at least one of the hetero rings does not contain nitrogen as ring hetero atom}
- C07H 19/06: Pyrimidine radicals
- A61K 31/7072: having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A61K 31/7076: containing purines, e.g. adenosine, adenylic acid
- A61K 31/708: having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
- A61P 31/14: for RNA viruses
- C07D 405/04: directly linked by a ring-member-to-ring-member bond
- C07D 473/18: one oxygen and one nitrogen atom, e.g. guanine
- C07D 473/34: attached in position 6, e.g. adenine
- C07F 9/65616: {containing the ring system [IMAGE cpc-sch-C07F-1006.gif] having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs}
- C07H 19/10: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H 19/16: Purine radicals
- C07H 19/20: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention provides a compound of formula I: (I) or a salt thereof, wherein R1-R4 have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as antiviral agents.

## Claims

### Claim 1

A compound of formula I
wherein:
R1 is H, —P(═X)(OH)—O—P(═O)(OH)—P(═O)(OH)2, or —P(═X)(Ra)(Rb);
R2 is H, F, Cl, Br, OH, (C1-C3)alkyl or (C1-C3)alkoxy, wherein any (C1-C3)alkyl and (C1-C3)alkoxy is optionally substituted with one or more halo;
R3 is H, F, Cl, Br, OH, (C1-C3)alkyl or (C1-C3)alkoxy, wherein any (C1-C3)alkyl and (C1-C3)alkoxy is optionally substituted with one or more halo;
R4 is selected from the group consisting of:
Ra is an N-linked amino acid or a (C1-C6)alkyl ester of an N-linked amino acid, wherein the (C1-C6)alkyl is optionally substituted with phenyl;
Rb is (C1-C6)alkoxy, aryloxy, or 5-10 membered heteroaryloxy, wherein any (C1-C6)alkoxy, aryloxy, and 5-10 membered heteroaryloxy is optionally substituted with one or more groups independently selected from the group consisting of halo, hydroxy, (C1-C3)alkoxy and (C1-C3)haloalkoxy;
Rc is (C1-C3)alkyl, hydroxymethyl, formyl or carboxy; and
X is S or O;
or a salt thereof.

### Claim 2 (depends on 1)

The compound or salt of claim 1, wherein R1 is H.

### Claim 3 (depends on 1)

The compound or salt of claim 1, wherein R1 is —P(═X)(OH)—O—P(═O)(OH)—P(═O)(OH)2.
or —P(═X)(Ra)(Rb).

### Claim 4 (depends on 1)

The compound or salt of claim 1, wherein R2 is F, Cl, Br, OH, (C1-C3)alkyl or (C1-C3)alkoxy, wherein any (C1-C3)alkyl and (C1-C3)alkoxy is optionally substituted with one or more (e.g., 1, 2, 3, or 4) halo.

### Claim 5 (depends on 1)

The compound or salt of claim 1, wherein R2 is H.

### Claim 6 (depends on 1)

The compound or salt of claim 1, wherein R2 is F, OH, or methoxy.

### Claim 7 (depends on 1)

The compound or salt of claim 1, wherein R2 is OH.

### Claim 8 (depends on 1)

The compound or salt of claim 1, wherein R3 is F, Cl, Br, OH, (C1-C3)alkyl or (C1-C3)alkoxy, wherein any (C1-C3)alkyl and (C1-C3)alkoxy is optionally substituted with one or more halo.

### Claim 9 (depends on 1)

The compound or salt of claim 1, wherein R3 is H.

### Claim 10 (depends on 1)

The compound or salt of claim 1, wherein R3 is methyl or F.

### Claim 11 (depends on 1)

The compound or salt of claim 1, wherein R4 is selected from the group consisting of:

### Claim at position 12

12-21. (canceled)

### Claim 22 (depends on 1)

The compound or salt of claim 1, wherein Ra is Rd—O—C(═O)—CH(Re)—NH—; wherein Rd is (C1-C6)alkyl that is optionally substituted with phenyl; and Re is the side-chain of a natural amino acid.

### Claim at position 14

23-25. (canceled)

### Claim 26 (depends on 1)

The compound or salt of claim 1, wherein Rb is phenoxy that is optionally substituted with one or more groups independently selected from the group consisting of halo, hydroxy, (C1-C3)alkoxy and (C1-C3)haloalkoxy.

### Claim 27

(canceled)

### Claim 28 (depends on 1)

The compound or salt of claim 1, wherein Rc is methyl, hydroxymethyl, formyl or carboxy.

### Claim at position 18

29-34. (canceled)

### Claim 35 (depends on 1)

The compound or salt of claim 1, wherein the compound of formula (I) is a compound of formula (Ic):

### Claim at position 20

36-38. (canceled)

### Claim 39 (depends on 1)

The compound of claim 1, which is selected from the group consisting of:
or a salt thereof.

### Claim 40

A compound selected from the group consisting of:
or a salt thereof.

### Claim 41

A compound selected from the group consisting of:
or a salt thereof.

### Claim 42 (depends on 1)

A pharmaceutical composition comprising a compound as described in claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient.

### Claim 43 (depends on 1)

A method for treating a viral infection in an animal comprising administering a compound of formula I as described in claim 1 or a pharmaceutically acceptable salt thereof to the animal.

### Claim at position 26

44-46. (canceled)
